Tilray Brands, Inc. (TLRY): R&D Expense

Annual figures by period end, from SEC filings.

$361.0K
Year ended 2026-05-31
-19.1%
3-year compound annual growth
-15.3%
5-year compound annual growth
$3.17M2016-12-31: $1.14M2017-12-31: $3.17M2019-05-31: $1.05M2020-05-31: $1.92M2021-05-31: $830.0K2022-05-31: $1.52M2023-05-31: $682.0K2024-05-31: $635.0K2025-05-31: $284.0K2026-05-31: $361.0K$361.0K
2016-12-31 R&D Expense (USD) 2026-05-31
Period endedR&D ExpenseChange YoYSource filing
2026-05-31$361.0K+27.1%2026-07-28, From 2025-06-01
2025-05-31$284.0K-55.3%2026-07-28, From 2024-06-01
2024-05-31$635.0K-6.9%2026-07-28, From 2023-06-01
2023-05-31$682.0K-55.1%2025-07-29, From 2022-06-01
2022-05-31$1.52M+82.9%2024-07-30, From 2021-06-01
2021-05-31$830.0K-56.7%2023-07-26, From 2020-06-01
2020-05-31$1.92M+82.1%2022-07-28, From 2019-06-01
2019-05-31$1.05Mn/a2021-07-28, From 2018-06-01
No annual figure between 2017-12-31 and 2019-05-31.
2017-12-31$3.17M+179.1%2020-03-02, From 2017-01-01
2016-12-31$1.14Mn/a2019-03-25, From 2016-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Tilray Brands, Inc. (TLRY)2026-05-31$361.0K+27.1%
USANA Health Sciences Inc (USNA)2026-01-03$10.69M-7.6%
Curaleaf Holdings, Inc. (CURLF)2025-12-31$805.0K-43.3%
Cronos Group Inc. (CRON)2025-12-31$4.45M+5.2%
Natural Alternatives International Inc (NAII)2025-06-30$1.80M-5.3%
Niagen Bioscience, Inc. (NAGE)2025-12-31$6.33M+5.2%
Mannatech Inc (MTEX)2025-12-31$800.0K+14.3%
Leef Brands Inc. (LEEEF)2025-12-31$19.7K+3.8%
Cyanotech Corp (CYAN)2025-03-31$449.0K-34.8%

Compare TLRY, USNA, CURLF, CRON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗